CVS Health Corp. will buy Oak Street Health Inc. for about $9.5 billion in cash, joining rivals in adding primary care to its portfolio as pressure mounts on its health insurance unit.
https://www.pharmalive.com/wp-content/uploads/2023/02/ReutersCVS2-8-2023.jpg8141200Reuters Healthhttps://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.pngReuters Health2023-02-08 10:24:172023-02-08 11:06:57CVS digs into primary care with $9.5B Oak Street Health deal
